A detailed history of High Tower Advisors, LLC transactions in Biodesix Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 131,434 shares of BDSX stock, worth $168,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
131,434
Previous 131,434 -0.0%
Holding current value
$168,235
Previous $201,000 15.92%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$1.2 - $2.13 $6,000 - $10,650
-5,000 Reduced 3.66%
131,434 $241,000
Q4 2022

Feb 08, 2023

BUY
$0.98 - $2.3 $133,705 - $313,798
136,434 New
136,434 $313,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $51.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.